SCHEMBL3585658

SCHEMBL3585658

CC(C)(N)CNC(=O)C(N)COCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 3/20 0.49
CTSS P25774 1/20 0.46
PPARA Q07869 2/20 0.44
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GHSR Q92847 2/20 0.42
TACR1 P25103 3/20 0.41
CA1 P00915 1/20 0.41
SLC1A3 P43003 2/20 0.40
SLC1A2 P43004 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
MMP9 P14780 1/20 0.40
MMP14 P50281 1/20 0.40
XIAP P98170 1/20 0.40
PPARG P37231 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9990986 0.83 SLC1A1 (0.50) SLC1A1CTSSPPARAHTTSMN1; SMN2
SCHEMBL17426 0.83 SLC1A1 (0.50) SLC1A1CTSSPPARAHTTSMN1; SMN2
SCHEMBL1576805 0.82 SLC1A1 (0.55) SLC1A1HTTSMN1; SMN2TACR1CA1
SCHEMBL14580892 0.81 SLC1A1 (0.54) SLC1A1HTTSMN1; SMN2TACR1MEN1
SCHEMBL13165228 0.81 SLC1A1 (0.54) SLC1A1HTTSMN1; SMN2TACR1MEN1
SCHEMBL27228895 0.80 SLC1A1 (0.56) SLC1A1PPARAHTTSMN1; SMN2TACR1
SCHEMBL27232206 0.80 SLC1A1 (0.56) SLC1A1PPARAHTTSMN1; SMN2TACR1
SCHEMBL3586820 0.80 SLC1A1 (0.52) SLC1A1HTTSMN1; SMN2TACR1CA1
SCHEMBL3580682 0.78 HTT (0.50) SLC1A1CTSSHTTSMN1; SMN2TACR1
SCHEMBL5209733 0.78 SLC1A1 (0.48) SLC1A1CTSSHTTSMN1; SMN2GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048549-A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 Wurster, Siegfried (FI) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048549-A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 SSTR1, SSTR4, SSTR3 SLC1A1 465/4885CTSS 1568/4885PPARA 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.